TY - JOUR
T1 - Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)
T2 - Leitlinie der Österreichischen Gesellschaft für Knochen- und Mineralstoffwechsel
AU - Dimai, Hans Peter
AU - Muschitz, Christian
AU - Amrein, Karin
AU - Bauer, Rosemarie
AU - Cejka, Daniel
AU - Gasser, Rudolf Wolfgang
AU - Gruber, Reinhard
AU - Haschka, Judith
AU - Hasenöhrl, Timothy
AU - Kainberger, Franz
AU - Kerschan-Schindl, Katharina
AU - Kocijan, Roland
AU - König, Jürgen
AU - Kroißenbrunner, Norbert
AU - Kuchler, Ulrike
AU - Oberforcher, Christine
AU - Ott, Johannes
AU - Pfeiler, Georg
AU - Pietschmann, Peter
AU - Puchwein, Paul
AU - Schmidt-Ilsinger, Alexander
AU - Zwick, Ralf Harun
AU - Fahrleitner-Pammer, Astrid
N1 - Funding Information:
Die Erstellung dieser Leitlinien wurde durch die \u00D6sterreichische Gesellschaft f\u00FCr Knochen- und Mineralstoffwechsel (\u00D6GKM) initiiert, geleitet und finanziert. Die Autorinnen und Autoren danken Dr. med. Uli Kiesswetter f\u00FCr das Projektmanagement sowie Unterst\u00FCtzung im Bereich Medical Writing. Dr. Margit Hemetsberger hat das Projekt im Bereich Medical Writing und Editierung unterst\u00FCtzt. Das Endlektorat erfolgte durch Mag. Heinz Javorsky. Die Unterst\u00FCtzung durch diese Personen wurde durch die \u00D6GKM finanziert. Die Kosten f\u00FCr Open Access Publikation und Copyright f\u00FCr relevante Abbildungen wurden durch die \u00D6GKM getragen. Die Erstellung dieser Leitlinien wurde durch die \u00D6sterreichische Gesellschaft f\u00FCr Knochen- und Mineralstoffwechsel (\u00D6GKM) initiiert, geleitet und finanziert.
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - BACKGROUND: Austria is among the countries with the highest incidence and prevalence of osteoporotic fractures worldwide. Guidelines for the prevention and management of osteoporosis were first published in 2010 under the auspices of the then Federation of Austrian Social Security Institutions and updated in 2017. The present comprehensively updated guidelines of the Austrian Society for Bone and Mineral Research are aimed at physicians of all specialties as well as decision makers and institutions in the Austrian healthcare system. The aim of these guidelines is to strengthen and improve the quality of medical care of patients with osteoporosis and osteoporotic fractures in Austria. METHODS: These evidence-based recommendations were compiled taking randomized controlled trials, systematic reviews and meta-analyses as well as European and international reference guidelines published before 1 June 2023 into consideration. The grading of recommendations used ("conditional" and "strong") are based on the strength of the evidence. The evidence levels used mutual conversions of SIGN (1++ to 3) to NOGG criteria (Ia to IV). RESULTS: The guidelines include all aspects associated with osteoporosis and osteoporotic fractures, such as secondary causes, prevention, diagnosis, estimation of the 10-year fracture risk using FRAX®, determination of Austria-specific FRAX®-based intervention thresholds, drug-based and non-drug-based treatment options and treatment monitoring. Recommendations for the office-based setting and decision makers and institutions in the Austrian healthcare system consider structured care models and options for osteoporosis-specific screening. CONCLUSION: The guidelines present comprehensive, evidence-based information and instructions for the treatment of osteoporosis. It is expected that the quality of medical care for patients with this clinical picture will be substantially improved at all levels of the Austrian healthcare system.
AB - BACKGROUND: Austria is among the countries with the highest incidence and prevalence of osteoporotic fractures worldwide. Guidelines for the prevention and management of osteoporosis were first published in 2010 under the auspices of the then Federation of Austrian Social Security Institutions and updated in 2017. The present comprehensively updated guidelines of the Austrian Society for Bone and Mineral Research are aimed at physicians of all specialties as well as decision makers and institutions in the Austrian healthcare system. The aim of these guidelines is to strengthen and improve the quality of medical care of patients with osteoporosis and osteoporotic fractures in Austria. METHODS: These evidence-based recommendations were compiled taking randomized controlled trials, systematic reviews and meta-analyses as well as European and international reference guidelines published before 1 June 2023 into consideration. The grading of recommendations used ("conditional" and "strong") are based on the strength of the evidence. The evidence levels used mutual conversions of SIGN (1++ to 3) to NOGG criteria (Ia to IV). RESULTS: The guidelines include all aspects associated with osteoporosis and osteoporotic fractures, such as secondary causes, prevention, diagnosis, estimation of the 10-year fracture risk using FRAX®, determination of Austria-specific FRAX®-based intervention thresholds, drug-based and non-drug-based treatment options and treatment monitoring. Recommendations for the office-based setting and decision makers and institutions in the Austrian healthcare system consider structured care models and options for osteoporosis-specific screening. CONCLUSION: The guidelines present comprehensive, evidence-based information and instructions for the treatment of osteoporosis. It is expected that the quality of medical care for patients with this clinical picture will be substantially improved at all levels of the Austrian healthcare system.
KW - Fracture probability
KW - FRAX
KW - Intervention threshold
KW - Monitoring
KW - Osteoporotic fracture
UR - http://www.scopus.com/inward/record.url?scp=85205526918&partnerID=8YFLogxK
U2 - 10.1007/s00508-024-02441-2
DO - 10.1007/s00508-024-02441-2
M3 - Artikel
C2 - 39356323
AN - SCOPUS:85205526918
SN - 0043-5325
VL - 136
SP - 599
EP - 668
JO - Wiener Klinische Wochenschrift
JF - Wiener Klinische Wochenschrift
IS - Suppl 16
ER -